Epstein-barr virus ebv 4-6 weeks




















In most cases, the antibody response occurs rapidly during primary EBV infection. However, the antibody pattern is not stable before symptoms appear. Skip directly to site content Skip directly to page options Skip directly to A-Z link. Epstein-Barr Virus and Infectious Mononucleosis. Section Navigation. Facebook Twitter LinkedIn Syndicate. Laboratory Testing.

Healy, Jens Kuhle, Michael J. Mina, Yumei Leng, Stephen J. Elledge, David W. Niebuhr, Ann I. Scher, Kassandra L. Munger, Alberto Ascherio. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science , DOI: ScienceDaily, 13 January Harvard T. Epstein-Barr virus may be leading cause of multiple sclerosis. J Infect Dis. Prognostic factors for chronic active Epstein-Barr virus infection. Dominant expression of interleukin and transforming growth factor-beta genes in activated T-cells of chronic active Epstein-Barr virus infection.

J Med Virol. Defective killer cell activity in patients with chronic active Epstein-Barr virus infection. Acta Med Okayama. Acta Paediatr Jpn. Can Med Assoc J. J Virol. Chronic active Epstein-Barr virus infection associated with mutations in perforin that impair its maturation. Oligonucleotide microarray analysis of gene expression profiles followed by real-time reverse-transcriptase polymerase chain reaction assay in chronic active Epstein-Barr virus infection. Chronic Epstein-Barr virus infection associated with fever and interstitial pneumonitis.

Clinical and serologic features and response to antiviral chemotherapy. Ann Intern Med. Ganciclovir for chronic active Epstein-Barr virus infection. Vidarabine therapy for severe chronic active Epstein-Barr virus infection.

J Pediatr Hematol Oncol. Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency? Rev Med Virol. Interferon-alpha therapy for chronic active Epstein-Barr virus infection: potential effect on the development of T-lymphoproliferative disease. Gamma-interferon for severe chronic active Epstein-Barr virus. Successful treatment of chronic active Epstein-Barr virus infection with recombinant interleukin Clin Exp Immunol.

Int J Hematol. Blood stem-cell transplantation for chronic active Epstein-Barr virus with lymphoproliferation. Bone Marrow Transplant. Successful control of Epstein-Barr virus EBV -infected cells by allogeneic nonmyeloablative stem cell transplantation in a patient with the lethal form of chronic active EBV infection. Am J Hematol. Complete resolution of severe chronic active Epstein-Barr virus infection by cultured, activated donor T lymphocyte infusion after nonmyeloablative stem cells allografting.

Clinical and virological characteristics of 15 patients with chronic active Epstein-Barr virus infection treated with hematopoietic stem cell transplantation. Clin Infect Dis. Successful umbilical cord blood transplantation for severe chronic active Epstein-Barr virus infection after the double failure of hematopoietic stem cell transplantation. Successful report of reduced-intensity stem cell transplantation from unrelated umbilical cord blood in a girl with chronic active Epstein-Barr infction.

Pediatric Transplantation.



0コメント

  • 1000 / 1000